Drug and toxin‐induced bile duct disorders

Abstract Various drugs of toxins have been implicated in the development of a particular form of liver damage predominantly involving the bile ducts. Such liver toxicity is often associated with a clinical picture of prolonged cholestasis and may even evolve in rare instances, into the full picture of the vanishing bile duct syndrome, eventually complicated with biliary cirrhosis. Drug and toxins potentially responsible for bile duct injury are reviewed as well as the characteristics of its clinical presentation. The pathophysiologic aspects of the syndrome are also reviewed including recent data, which are strongly in favor of the role of a genetic predisposition.

[1]  B. Stricker,et al.  Flucloxacillin-associated hepatic injury. , 2008, Liver.

[2]  Y. Ueno,et al.  A case of drug-induced ductopenia resulting in fatal biliary cirrhosis. , 2008, Liver.

[3]  Y. Horsmans,et al.  Reversible cholestasis with bile duct injury following azathioprine therapy. A case report. , 2008, Liver.

[4]  A. Geubel,et al.  Prolonged cholestasis and disappearance of interlobular bile ducts following chlorpropamide and erythromycin ethylsuccinate. Case of drug interaction? , 2008, Liver.

[5]  V. Desmet.  Histopathology of the intrahepatic biliary tree. , 2008, Liver.

[6]  C. Wegmann,et al.  Ticlopidin-induzierte akute cholestatische Hepatitis , 2008 .

[7]  C. Sempoux,et al.  HLA association of amoxicillin-clavulanate--induced hepatitis. , 1999, Gastroenterology.

[8]  D. Schuppan,et al.  Acute hepatitis induced by greater celandine (Chelidonium majus). , 1999, Gastroenterology.

[9]  M. Jonas,et al.  Drug-associated acute-onset vanishing bile duct and Stevens-Johnson syndromes in a child. , 1998, Gastroenterology.

[10]  J. Ludwig.  Idiopathic adulthood ductopenia: an update. , 1998, Mayo Clinic proceedings.

[11]  M. Letizia,et al.  Drug-induced hepatic injury. , 1997, Medsurg nursing : official journal of the Academy of Medical-Surgical Nurses.

[12]  L. Love,et al.  Chaparral-associated hepatotoxicity. , 1997, Archives of internal medicine.

[13]  A. Moreno,et al.  Idiopathic biliary ductopenia in adults without symptoms of liver disease. , 1997, The New England journal of medicine.

[14]  L. Gramlich,et al.  Intravenous ursodeoxycholic acid reduces cholestasis in parenterally fed newborn piglets. , 1996, Gastroenterology.

[15]  L. Ferrell,et al.  Vanishing bile duct syndrome temporally associated with ibuprofen use. , 1996, American Journal of Gastroenterology.

[16]  K. Reddy,et al.  Drug-induced vanishing bile duct syndrome: response to ursodiol. , 1996, The American journal of gastroenterology.

[17]  E. Tsimoyiannis,et al.  Secondary sclerosing cholangitis: after injection of formaldehyde into hydatid cysts in the liver. , 1995, The European journal of surgery = Acta chirurgica.

[18]  K. Washington,et al.  Tetracycline-induced bile duct paucity and prolonged cholestasis. , 1994, Gastroenterology.

[19]  D. Moradpour,et al.  Chlorpromazine‐induced vanishing bile duct syndrome leading to biliary cirrhosis , 1994, Hepatology.

[20]  S. Goldfarb,et al.  Cholestatic hepatitis after ingestion of chaparral leaf: confirmation by endoscopic retrograde cholangiopancreatography and liver biopsy. , 1994, Journal of clinical gastroenterology.

[21]  Y. Horsmans,et al.  Vanishing bile duct syndrome occurring after carbamazepine administration: a second case report. , 1994, Journal of clinical gastroenterology.

[22]  G. Mazzucco,et al.  Propafenone-induced liver injury: report of a case and review of the literature. , 1993, Gastroenterology.

[23]  E. Keeffe,et al.  Prolonged cholestasis due to trimethoprim sulfamethoxazole. , 1992, Gastroenterology.

[24]  G. Jeffrey,et al.  Carbamazepine hepatotoxicity: another cause of the vanishing bile duct syndrome. , 1992, Gastroenterology.

[25]  D. Larrey,et al.  Hepatitis associated with amoxycillin-clavulanic acid combination report of 15 cases. , 1992, Gut.

[26]  C. Degott,et al.  Drug‐induced prolonged cholestasis in adults: A histological semiquantitative study demonstrating progressive ductopenia , 1992, Hepatology.

[27]  R. Botero,et al.  Chronic cholestasis, paucity of bile ducts, red cell aplasia, and the Stevens-Johnson syndrome. An ampicillin-associated case. , 1990, Gastroenterology.

[28]  S. Henzen‐Logmans,et al.  Hyperbilirubinaemia in patients treated with recombinant human interleukin-2 (rIL-2) , 1990, British Journal of Cancer.

[29]  F. Prat,et al.  [Sclerosing cholangitis caused by sterilization of a hydatid cyst of the liver with a hypertonic saline solution]. , 1988, Gastroenterologie clinique et biologique.

[30]  M. Rizzetto,et al.  Hepatitis Delta Virus Infection of the Liver: Progress in Virology, Pathobiology, and Diagnosis , 1988, Seminars in liver disease.

[31]  D. Larrey,et al.  9 Drug-induced cholestasis , 1988 .

[32]  M. Vyberg,et al.  Acute cholangitis and pancreatitis associated with sulindac (clinoril) , 1987, Histopathology.

[33]  A. Kitabchi,et al.  Glyburide-induced hepatitis. , 1987, Annals of internal medicine.

[34]  D. Pessayre,et al.  Prolonged cholestasis after cyproheptadine-induced acute hepatitis. , 1987, Journal of clinical gastroenterology.

[35]  L. Berland,et al.  Causes of jaundice during hepatic artery infusion chemotherapy. , 1986, Radiology.

[36]  J. Belghiti,et al.  Caustic sclerosing cholangitis. A complication of the surgical treatment of hydatid disease of the liver. , 1986, Archives of surgery.

[37]  C. Babbs,et al.  Primary biliary cirrhosis after benoxaprofen. , 1986, British medical journal.

[38]  M. Makuuchi,et al.  Bile duct necrosis: complication of transcatheter hepatic arterial embolization. , 1985, Radiology.

[39]  M. Kemeny,et al.  Sclerosing Cholangitis after Continuous Hepatic Artery Infusiori of FUDR , 1985, Annals of surgery.

[40]  J. Myers,et al.  Hydralazine-induced cholangitis. , 1984, Gastroenterology.

[41]  C. Felsenheld,et al.  [Pericholangitis in an adult treated with clometacin]. , 1983, Gastroenterologie clinique et biologique.

[42]  N. Gibbs.  Large paraffin sections and chemical clearance of axillary tissues as a routine procedure in the pathological examination of the breast , 1982, Histopathology.

[43]  M. Lévy,et al.  Granulomatous hepatitis secondary to carbamazepine. , 1981, Annals of internal medicine.

[44]  R. Williams,et al.  Hepatitis from dantrolene sodium. , 1979, Gut.

[45]  Ishak Kg,et al.  Hepatic injury associated with the phenothiazines. Clinicopathologic and follow-up study of 36 patients. , 1972 .

[46]  G. Campesi,et al.  Barbiturate jaundice. Report of a case due to a barbital-containing drug, with positive rechallenge to phenobarbital. , 1969, Gastroenterology.

[47]  M. Swain,et al.  Familial idiopathic adulthood ductopenia: a report of five cases in three generations. , 2000, Journal of hepatology.

[48]  H. Huchzermeyer,et al.  [Ticlopidine-induced acute cholestatic hepatitis]. , 1998, Deutsche medizinische Wochenschrift.

[49]  T. Sauerbruch,et al.  Anomalous expression of costimulatory molecules B7-1, B7-2 and CD28 in primary biliary cirrhosis. , 1997, Journal of hepatology.

[50]  V. Desmet.  Vanishing bile duct syndrome in drug-induced liver disease. , 1997, Journal of hepatology.

[51]  S. Saab,et al.  Trimethoprim-sulfamethoxazole-induced vanishing bile duct syndrome. , 1997, The American journal of gastroenterology.

[52]  Y. Horsmans,et al.  Liver injury related to amoxycillin-clavulanic acid: interlobular bile-duct lesions and extrahepatic manifestations. , 1995, Journal of hepatology.

[53]  N. Kawada,et al.  [Drug-induced cholestasis]. , 1995, Ryoikibetsu shokogun shirizu.

[54]  P. Blanc,et al.  Tianeptine--an instance of drug-induced hepatotoxicity predicted by prospective experimental studies. , 1994, Journal of hepatology.

[55]  B. Stricker,et al.  Terbinafine-associated hepatic injury. , 1994, Journal of hepatology.

[56]  D. Dhumeaux,et al.  [Chronic lesion of the interlobular bile ducts induced by fenofibrate]. , 1994, Gastroenterologie clinique et biologique.

[57]  R. Chapman,et al.  Dextropropoxyphene induced hepatotoxicity: a report of nine cases. , 1993, Journal of hepatology.

[58]  D. Pessayre.  Physiopathologie des hépatopathies médicamenteuses , 1993 .

[59]  D. Larrey,et al.  Pathologie biliaire due aux médicaments , 1993 .

[60]  Y. Horsmans,et al.  Les cholestases médicamenteuses secondaires à une atteinte canalaire. , 1991 .

[61]  J. Keating,et al.  Intrahepatic cholestasis secondary to gold therapy , 1991 .

[62]  Y. Horsmans,et al.  [Secondary drug-induced cholestasis with bile duct involvement]. , 1991, Acta gastro-enterologica Belgica.

[63]  A. Lok,et al.  Prochlorperazine-induced chronic cholestasis. , 1988, Journal of hepatology.

[64]  F. Prat,et al.  Cholangite sclérosante secondaire à la stérilisation d'un kyste hydatique du foie par une solution salée hypertonique. , 1988 .

[65]  C. Felsenheld,et al.  Péricholangite chez un adulte traité par clométacine. , 1983 .

[66]  H. Zimmerman.  Hepatotoxicity: The adverse effects of drugs and other chemicals on the liver , 1978 .